Guidelines
Created date：February 15th, 2018
JSPHO publication guidelines.
A practical guideline for pediatric leukemia and lymphoma (Japanese version).
Pdfs of these guidelines are available at the links below.
Unauthorized reproduction is prohibited.
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/3rd_Edition_Foreword.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Creator_committee.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/2nd_Edition_Foreword.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/1st_Edition_Foreword.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/table_of_contents.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Basic_matters.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Acute_lymphocytic_leukemia_ALL.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Acute_myelogenous_leukemia_AML.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Chronic_myelogenous_leukemia_CML.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Myelodysplastic_syndrome_MDS.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Lymphoma.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Langerhans_cell_histiocytosis_LCH.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Supportive_therapy.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Abbreviation_list.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/Drug_name_list.pdf
- » https://www.jspho.org/pdf/journal/childhood_leukemia_lymphoma_guideline/index.pdf
Practical guidelines for pediatric cancer (Japanese version).
Pdfs of these guidelines are available at the links below.
Unauthorized reproduction is prohibited.
- » https://www.jspho.org/pdf/journal/2016_guideline/2nd_Edition_Foreword.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Creator_committee.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/1st_Edition_Foreword.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/table_of_contents.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Basic_matters.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Childhood_liver_cancer.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Pediatric_renal_tumor.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Osteosarcoma.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Central_nerve_germ_cell_tumor.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Retinoblastoma.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Neuroblastoma.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Rhabdomyosarcoma.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Ewing_sarcoma_family_tumor.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Other_rare_tumors.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Tumor_biopsy_central_route.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Abbreviation_list.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/Drug_name_list.pdf
- » https://www.jspho.org/pdf/journal/2016_guideline/index.pdf